Diabetic KetoAcidosis is a condition of formation of ketone bodies in body due to which body goes to acidic condition and this is due to elevated glucose levels in blood.

1. A CASE STUDY ON DIABETIC KETOACIDOSIS
VIGNAN PHARMACY COLLEGE
(Approved by AICTE, PCI- New Delhi and affiliated to JNTUK)
Vadlamudi, Guntur (dist), Pincode: 522213
PRESENTED BY:
Musheera Shaik
V Pharm D
19AB1T0023
UNDER THE GUIDANCE OF :
Dr. M. Satyavathi
Assistant Professor
Pharm. D

2. Patient Details:
NAME: XXXX
GENDER: Male
AGE:59 years
DEPARTMENT: General Medicine
IPNO : IPGN-231000570
UMR NO : GN-231000988

3. SUBJECTIVE
C/O
 Abdominal pain and burning during micturition since 15 days , Fever and vomitings since
one day and constipation
OBJECTIVE:
PAST MEDICAL HISTORY:
 Diabetes mellitus
PAST MEDICATION HISTORY:
 Nil
HISTORY OF PRESENT ILLNESS:
Nil
Family/Surgical/Allergies: nil

4. • Physical Examination:
Cardiovascular system: NAD
Central nervous system: NAD
respiratory system: NAD
GIT: NAD
Head, eyes, ears, nose, throat: NAD.
Dermatology: NAD.
Extremities: NAD.
Pharmacist considerations: Nil.
Laboratory investigations
Vitals.
Temperature- 105.5
BP- 120 / 70
Pulse- 103
RR-18

5. LAB INVESTIGATIONS
PARAMETERS RESULTS REFERENCE
Hb 14 12-16.5
PCV 33 35-50
Lymphocytes 55 15-30%
Neutrophils 74 40-70%
Platelets 3.42 1-4 lac/cum
RBC 5.41 3.8-5.8 lac/cum
WBC 12700 4000-11000 cells/ cum
Clotting time 4min 15 sec
Bleeding time 2 min
Sodium 130 135-145 mEq/l
Potassium 4.1 3.5-5.5 mEq/l
BLOOD GROUP : O +ve

6. PARAMETER RESULT
Albumin 7.03g/L
Sugar +++ ≥55mmol/L
WBC 8-10/ HPF
Epithelial cells 2-3/HPF
Ketone bodies +++≥8.0mmol/L
LIVER FUNCTION TESTS
PARAMETER RESULT
Total Proteins [6.8 – 8.3g/dl] 6.4
SGOT/AST [6-3u/I] 27
SGPT/ALT[6-34 u/I] 27
ALP[36-142 mu/ml] 134
Bilirubin Total [0.5-1.1 mg/dl] 0.9
Bilirubin Direct [ upto 3mg/dl] 0.5
Bilirubin Indirect 0.4

7. DIAGNOSIS:
Urosepsis with Diabetic Ketoacidosis
ASSESMENT:
Based on the past medical history, chief complaints and abnormal values of the patient was to
diagnosed as Urosepsis with Diabetic Ketoacidosis.

8. TREATMENT:
S.no TRADE
NAME
GENERIC
NAME
R.O.A DOSE FREQUENCY Day-1 Day-2
1 Inj. Magnex
Forte
Ceftriaxone +
sulbactam
IV 1.5 g 1-0-1 ✔ ✔
2 Inj.Pantop Pantoprazol
e
IV 40mg 1-0-0 ✔ ✔
3 Inj.
Optineuron
MVI IV 1amp 1-0-1 ✔ ✔
4 Neb. Asthalin Ipratropium
bromide
PN 4resp 1-1-1-1 ✔ stop
5 Sachet K-Bind Potassium
supplement
PO 1sachet 0-0-1 ✔ ✔

9. S.N
O
TRADE NAME GENERIC
NAME
ROA DOSE FREQUENCY DAY 1 DAY 2
6 Syp. Cremaffin Liq paraffin
+Mg (OH)2
PO 15ml 0-0-1 ✔ ✔
7 Inj. Zofer Ondansetro
n
IV 4mg SOS
8 Inj. Trexiba Insulin SC 20U OD ✔ ✔
9 Inj. HAI Insulin SC 15U 1-0-1 ✔ ✔